Recombinant or Synthetic Nucleic Acid Molecules or Biohazardous Materials

UPDATED 3/9/2022:

If you have any questions about IBC operations or in general please direct them to Cu_ibc@cornell.edu

The Institutional Biosafety Committee (IBC) reviews and approves work using recombinant or synthetic nucleic acids (r/sNA) and/or biohazardous materials.

Before starting work with r/sNA or biohazardous materials, registration with the Institutional Biosafety Committee is required. Depending on the nature of the proposed research, approval may also be required by the IACUC, and Institutional Review Board

Institutional Biosafety Committee's primary objective is to safeguard the protection of personnel, the general public, and the environment. To meet this goal, the IBC reviews and approves research for safe laboratory and biological safety practices, policies, procedures, training, programs, and facilities pursuant to the safe use of r/sNA, biohazardous materials, and biotoxins.

Submit an Application, Amendment, or Renewal

All researchers must secure IBC approval for their activities with recombinant or synthetic nucleic acid molecules (r/sNA) or biohazardous materials by submitting a Memorandum of Understanding and Agreement (MUA) with the IBC. See more details on the IBC Application Submission, Review and Approval page.

All personnel listed on the MUA who work with human materials or bloodborne pathogens and diseases must receive training prior to starting work.

About Environment, Health and Safety (EHS)

Research Safety, part of Environment, Health and Safety, is staffed by a team of Biological Safety, Chemical and Laboratory Safety, and Radiation Safety professionals who have the expertise to assist researchers mitigate and manage the risks associated with their research and meet regulatory and compliance requirements. See the Research Safety page for more information.